Compounds > 2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine
Page last updated: 2024-10-15
2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine
Description
2-amino-4-oxo-6-acetyl-7,8-dihydro-3H,9H-pyrimidodiazepine: a 6-acetylpyrimidodiazepine intermediate in biosyn of drosopterin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
6-acetyl-2-amino-3,7,8,9-tetrahydropyrimido[4,5-b][1,4]diazepin-4-one : A member of the class of pyrimidodiazepine 3,7,8,9-tetrahydropyrimido[4,5-b][1,4]diazepin-4-one bearing amino and acetyl substituents at positions 2 and 6 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 135398683 |
| CHEBI ID | 27714 |
| SCHEMBL ID | 20956399 |
| MeSH ID | M0100610 |
Synonyms (15)
| Synonym |
|---|
| aoadpd |
| C02587 |
| 2-amino-6-acetyl-3,7,8,9-tetrahydro-3h-pyrimido[4,5-b][1,4]diazepin-4-one |
| 6-acetyl-2-amino-3,7,8,9-tetrahydropyrimido[4,5-b][1,4]diazepin-4-one |
| 80003-63-0 |
| 6-acetyldihydrohomopterin |
| 6-acetylhomopterin |
| 4h-pyrimido(4,5-b)(1,4)diazepin-4-one, 6-acetyl-2-amino-1,7,8,9-tetrahydro- |
| quench spot |
| 2-amino-4-oxo-6-acetyl-7,8-dihydro-3h,9h-pyrimidodiazepine |
| DTXSID60230003 |
| CHEBI:27714 |
| 6-acetyl-2-amino-3,7,8,9-tetrahydro-4h-pyrimido[4,5-b]-[1,4]diazepin-4-one |
| SCHEMBL20956399 |
| Q27103277 |
Roles (1)
| Role | Description |
|---|
| metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| pyrimidodiazepine | |
| methyl ketone | A ketone of formula RC(=O)CH3 (R =/= H). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |